VESIcare Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome
Condition:   Urinary Incontinence Interventions:   Drug: Solifenacin Succinate;   Device: Neuro-Muscular Stimulators (NMS) Sponsor:   Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2018 Category: Research Source Type: clinical trials